Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04536376 · ClinicalTrials.gov registry record · NA

First Responder Resiliency Program During COVID-19

A NA study of Stress and Sleep, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04536376: Completed NA study of Stress and Sleep, sponsored by Mayo Clinic.

NCT04536376 is a NA study of Stress and Sleep that has completed, run by Mayo Clinic. The registered enrollment target is 10 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04536376, a NA study of Stress and Sleep, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Evaluating a wellness program developed to provide effective sustainable solutions for medical professionals providing care to COVID-19 pandemic patients.

Primary Outcome

Perceived Stress Scale (PSS) is a 10-item Likert scale scoring system that measures global life stress by assessing the degree to which experiences are appraised as uncontrollable or unpredictable. Scores can range from 0 to 40, with higher scores indicating greater perceived stress. The outcome was analyzed as change from baseline

Interventions

  • BEHAVIORAL Resilience Program

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2021-01-15
Est. Completion 2022-12-31
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT04536376 record still lists

NCT04536376 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 786-participant average among 152 other Stress trials with a reported enrollment target (99% lower).

The record links to 3 conditions, with Stress appearing as the primary indexed condition, and to 1 intervention - of which Resilience Program is the first listed.

NCT04536376 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT04536376 about?

NCT04536376 is a clinical study titled "First Responder Resiliency Program During COVID-19". Evaluating a wellness program developed to provide effective sustainable solutions for medical professionals providing care to COVID-19 pandemic patients.

What is the current status of trial NCT04536376?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2021-01-15. Estimated completion is 2022-12-31.

What conditions does trial NCT04536376 study?

This clinical trial studies the following conditions: Stress, Sleep, Resilience.

What interventions are being tested in trial NCT04536376?

The interventions under investigation include: Resilience Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT04536376?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04536376 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04536376's enrollment target sits among peer trials

10 150th of 152 higher than 2 of 152 other Stress trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Stress trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04536376, the US trial registry maintained by the National Library of Medicine. NCT04536376 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.